ETFChannel.com
SLIDESHOW: The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks
By ETF Channel Staff, updated Tue, July 27, 5:31 AM
| This Slide: #1 of 15 |
#15 of the Dow 30: Merck & Co Inc (NYSE:MRK)
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products. 
Open the MRK Page at ETF Channel »
|
|||||||||||||||||||||
Open the ETF Channel MRK Page (in a new window) »
MRK Average Broker Rec.
 
|
Buy (3.17 out of 4) 32nd percentile
(ranked lower than approx. 68% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
| Avg. Broker Rec.
|
Buy (3.17 out of 4) 32nd percentile
(ranked lower than approx. 68% of all stocks covered)
Analysts Forecast: MRK Price Target Based on data provided by Zacks Investment Research via Quandl.com |
|
|
